These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 26903584)

  • 21. Cross-cultural difference and validation of the Chinese version of Montreal Cognitive Assessment in older adults residing in Eastern China: preliminary findings.
    Hu JB; Zhou WH; Hu SH; Huang ML; Wei N; Qi HL; Huang JW; Xu Y
    Arch Gerontol Geriatr; 2013; 56(1):38-43. PubMed ID: 22698678
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cross validation of the Montreal Cognitive Assessment in community dwelling older adults residing in the Southeastern US.
    Luis CA; Keegan AP; Mullan M
    Int J Geriatr Psychiatry; 2009 Feb; 24(2):197-201. PubMed ID: 18850670
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Validation of the Telephone Interview of Cognitive Status and Telephone Montreal Cognitive Assessment Against Detailed Cognitive Testing and Clinical Diagnosis of Mild Cognitive Impairment After Stroke.
    Zietemann V; Kopczak A; Müller C; Wollenweber FA; Dichgans M
    Stroke; 2017 Nov; 48(11):2952-2957. PubMed ID: 29042492
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Underestimation of cognitive impairments by the Montreal Cognitive Assessment (MoCA) in an acute stroke unit population.
    Chan E; Khan S; Oliver R; Gill SK; Werring DJ; Cipolotti L
    J Neurol Sci; 2014 Aug; 343(1-2):176-9. PubMed ID: 24880539
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Validity of the Montreal Cognitive Assessment Screener in Adolescents and Young Adults With and Without Congenital Heart Disease.
    Pike NA; Poulsen MK; Woo MA
    Nurs Res; 2017; 66(3):222-230. PubMed ID: 28448372
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Validation of the Montreal cognitive assessment versus mini-mental state examination against hypertension and hypertensive arteriopathy after transient ischemic attack or minor stroke.
    Webb AJ; Pendlebury ST; Li L; Simoni M; Lovett N; Mehta Z; Rothwell PM
    Stroke; 2014 Nov; 45(11):3337-42. PubMed ID: 25248911
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Montreal Cognitive Assessment (MoCA): validation study for frontotemporal dementia.
    Freitas S; Simões MR; Alves L; Duro D; Santana I
    J Geriatr Psychiatry Neurol; 2012 Sep; 25(3):146-54. PubMed ID: 22859702
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Brief screening for mild cognitive impairment: validation of the Brazilian version of the Montreal cognitive assessment.
    Memória CM; Yassuda MS; Nakano EY; Forlenza OV
    Int J Geriatr Psychiatry; 2013 Jan; 28(1):34-40. PubMed ID: 22368034
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The test accuracy of the Montreal Cognitive Assessment (MoCA) by stroke lateralisation.
    Chan E; Altendorff S; Healy C; Werring DJ; Cipolotti L
    J Neurol Sci; 2017 Feb; 373():100-104. PubMed ID: 28131163
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Montreal Cognitive Assessment for the screening and prediction of cognitive decline in early Parkinson's disease.
    Kandiah N; Zhang A; Cenina AR; Au WL; Nadkarni N; Tan LC
    Parkinsonism Relat Disord; 2014 Nov; 20(11):1145-8. PubMed ID: 25176439
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Brief screening tool for mild cognitive impairment in older Japanese: validation of the Japanese version of the Montreal Cognitive Assessment.
    Fujiwara Y; Suzuki H; Yasunaga M; Sugiyama M; Ijuin M; Sakuma N; Inagaki H; Iwasa H; Ura C; Yatomi N; Ishii K; Tokumaru AM; Homma A; Nasreddine Z; Shinkai S
    Geriatr Gerontol Int; 2010 Jul; 10(3):225-32. PubMed ID: 20141536
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Feasibility of the Montreal Cognitive Assessment in acute stroke patients.
    Horstmann S; Rizos T; Rauch G; Arden C; Veltkamp R
    Eur J Neurol; 2014 Nov; 21(11):1387-93. PubMed ID: 25040216
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The informant AD8 is superior to participant AD8 in detecting cognitive impairment in a memory clinic setting.
    Dong Y; Pang WS; Lim LB; Yang YH; Morris JC; Hilal S; Venketasubramanian N; Chen CL
    J Alzheimers Dis; 2013; 35(1):159-68. PubMed ID: 23380993
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The validity of the Montreal cognitive assessment (MoCA) for the screening of vascular cognitive impairment after ischemic stroke.
    Potocnik J; Ovcar Stante K; Rakusa M
    Acta Neurol Belg; 2020 Jun; 120(3):681-685. PubMed ID: 32193731
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Validation of the Montreal Cognitive Assessment (MoCA) as a screening tool for mild cognitive impairment in the population of Buenos Aires, Argentina].
    González Palau F; Berrios W; García Basalo MM; Ojea Quintana M; Fernández M; García Basalo MJ; Fernández MC; Cámpora N; Matusevich LD; Golimstok Á
    Vertex; 2018 Jul; XXIX(140):261-269. PubMed ID: 30778419
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Stroke Location Is an Independent Predictor of Cognitive Outcome.
    Munsch F; Sagnier S; Asselineau J; Bigourdan A; Guttmann CR; Debruxelles S; Poli M; Renou P; Perez P; Dousset V; Sibon I; Tourdias T
    Stroke; 2016 Jan; 47(1):66-73. PubMed ID: 26585396
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Predictive value of MoCA in the acute phase of stroke on the diagnosis of mid-term cognitive impairment.
    Salvadori E; Pasi M; Poggesi A; Chiti G; Inzitari D; Pantoni L
    J Neurol; 2013 Sep; 260(9):2220-7. PubMed ID: 23716072
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Validity of the montreal cognitive assessment (MoCA) as a screening test for mild cognitive impairment (MCI) in a cardiovascular population.
    McLennan SN; Mathias JL; Brennan LC; Stewart S
    J Geriatr Psychiatry Neurol; 2011 Mar; 24(1):33-8. PubMed ID: 21156989
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Montreal Cognitive Assessment and Mini-Mental State Examination performance in patients with mild-to-moderate dementia with Lewy bodies, Alzheimer's disease, and normal participants in Taiwan.
    Wang CS; Pai MC; Chen PL; Hou NT; Chien PF; Huang YC
    Int Psychogeriatr; 2013 Nov; 25(11):1839-48. PubMed ID: 23919950
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Montreal Cognitive Assessment Performance in HIV/AIDS: Impact of Systemic Factors.
    Koenig N; Fujiwara E; Gill MJ; Power C
    Can J Neurol Sci; 2016 Jan; 43(1):157-62. PubMed ID: 26635008
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.